Robots take aim at lung nodules: could precision ablation replace surgery?

NCT ID NCT07389889

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This trial tests whether a robot can help doctors more accurately target and destroy small lung nodules (ground-glass opacities) using microwave heat, compared to the standard CT-guided method. About 116 adults with early-stage lung cancer who cannot have surgery will be randomly assigned to one of the two techniques. The main goal is to see if the robot improves first-attempt puncture success and reduces complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
microwave ablation
What this could lead to
If successful, robot-guided ablation could become a more precise and safer option for treating early-stage lung nodules without surgery.
What could go wrong
This is an early-stage trial with only 116 participants, so results may not apply broadly. The robot may not improve outcomes enough to justify its cost or complexity.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GROUND-GLASS OPACITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Multiple Pulmonary Nodules

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.